background
newli
emerg
influenza
viru
new
viru
caus
first
influenza
pandem
centuri
three
influenza
pandem
previou
centuri
caus
variabl
mortal
larg
depend
develop
sever
pneumonia
howev
abil
new
viru
caus
pneumonia
poorli
understood
method
new
viru
inocul
intratrach
ferret
abil
caus
pneumonia
compar
season
influenza
viru
highli
pathogen
avian
influenza
hpai
viru
use
clinic
virolog
patholog
analys
result
result
show
new
viru
caus
pneumonia
ferret
intermedi
sever
caus
season
viru
hpai
viru
new
viru
replic
well
throughout
lower
respiratori
tract
extens
season
viru
replic
mainli
bronchi
hpai
viru
replic
mainli
alveoli
high
load
new
viru
lung
tissu
associ
diffus
alveolar
damag
mortal
conclus
new
viru
may
intrins
pathogen
human
season
viru
new
influenza
viru
subtyp
new
viru
first
emerg
mexico
begin
first
pandem
human
influenza
viru
centuri
studi
conclud
viru
probabl
origin
domest
swine
reservoir
basi
genet
signatur
june
world
health
organ
declar
phase
global
pandem
alert
level
case
includ
death
countri
offici
report
main
concern
new
influenza
pandem
diseas
burden
associ
mortal
may
caus
larg
due
pneumonia
result
extens
viral
infect
lower
respiratori
tract
initi
lung
damag
may
complic
concomit
subsequ
bacteri
pneumonia
shown
major
caus
mortal
spanish
influenza
epidem
use
antibiot
current
outbreak
new
influenza
bacteri
coinfect
regist
case
investig
contrast
damag
caus
viru
infect
tracheobronchi
epithelium
uncompl
influenza
damag
alveolar
epithelium
sever
consequ
ga
exchang
function
respiratori
tract
allow
fluid
alveolar
capillari
flood
alveolar
lumina
caus
severeand
case
fatalrespiratori
dysfunct
basi
observ
rel
low
case
fatal
rate
human
assum
virul
new
viru
low
howev
acknowledg
figur
uncertain
limit
data
therefor
potenti
new
viru
caus
lower
respiratori
tract
diseas
human
still
poorli
understood
previou
public
use
intranas
inocul
influenza
viru
ferret
mainli
model
transmiss
new
viru
human
use
intratrach
inocul
influenza
viru
ferret
model
influenza
pneumonia
human
intratrach
rout
inocul
appropri
model
infect
human
commonli
thought
occur
inhal
infecti
droplet
airborn
droplet
nuclei
use
rout
inocul
success
previou
studi
involv
ferret
macaqu
studi
design
surviv
studi
group
ferret
season
viru
ferret
new
hpai
virus
temperatur
logger
periton
caviti
inocul
intratrach
virus
follow
dose
volum
median
tissu
cultur
infect
dose
tcid
viru
inocul
monitor
daili
clinic
sign
maxim
day
inocul
pneumonia
studi
group
ferret
season
viru
ferret
new
hpai
virus
inocul
intratrach
tcid
viru
euthan
day
inocul
earlier
moribund
time
point
necropsi
perform
sampl
obtain
respiratori
extrarespiratori
tissu
virolog
patholog
immunohistochem
analys
ferret
experi
perform
biosafeti
level
condit
netherland
vaccin
institut
anim
studi
protocol
approv
institut
anim
welfar
committe
thirteenmonthold
purposebr
ferret
seroneg
antibodi
circul
influenza
virus
aleutian
diseas
viru
maintain
standard
hous
provid
commerci
food
pellet
water
ad
libitum
start
experi
ferret
femal
bodi
weight
g
except
male
new
viru
season
viru
group
pneumonia
studi
bodi
weight
g
respect
two
week
infect
anim
anesthet
use
cocktail
ketamin
nimatek
eurovet
anim
health
bv
domitor
orion
pharma
temperatur
logger
data
storag
tag
microt
ultra
small
temperatur
logger
staroddi
place
periton
caviti
devic
record
bodi
temperatur
anim
everi
min
patholog
three
anim
group
euthan
exsanguin
ketamin
anesthesia
day
inocul
necropsi
perform
accord
standard
protocol
trachea
clamp
lung
would
deflat
upon
open
pleural
caviti
allow
visual
estim
area
affect
lung
parenchyma
sampl
histolog
examin
store
neutralbuff
formalin
lung
inflat
formalin
embed
paraffin
section
mm
stain
hematoxylin
eosin
examin
light
microscopi
follow
tissu
examin
light
microscopi
left
lung
cranial
caudal
lobe
nasal
turbin
nasal
septum
larynx
trachea
bronchu
tracheobronchi
lymph
node
eyelid
tonsil
heart
liver
spleen
kidney
pancrea
duodenum
jejunum
colon
adren
gland
brain
sampl
obtain
lung
standard
way
guid
chang
seen
gross
patholog
semiquantit
assess
influenza
virusassoci
inflamm
lung
perform
report
elsewher
alveoli
degre
inflamm
bronchi
bronchiol
use
bronchial
bronchiolar
epithelium
inflam
bronchial
bronchiolar
epithelium
inflam
bronchial
bronchiolar
epithelium
inflam
sever
inflamm
bronchi
bronchiol
score
peribronchi
peribronchiolar
infiltr
mild
necrosi
moder
number
inflammatori
cell
scant
exud
mark
necrosi
larg
number
inflammatori
cell
abund
exud
microscopi
slide
examin
without
knowledg
ident
anim
cumul
score
size
sever
inflamm
provid
total
score
per
anim
immunohistochem
analysi
detect
influenza
viru
antigen
tissu
stain
primari
antibodi
influenza
nucleoprotein
describ
elsewher
semiquantit
assess
influenza
viru
antigen
express
lung
perform
report
elsewher
alveoli
bronchi
bronchiol
percentag
posit
stain
bronchial
bronchiolar
epithelium
estim
everi
slide
averag
slide
taken
provid
score
per
anim
phenotyp
alveolar
epitheli
cell
use
destainingrestain
techniqu
describ
elsewher
virolog
viru
titer
determin
viru
isol
madindarbi
canin
kidney
cell
upon
necropsi
sampl
g
cranial
median
caudal
lobe
right
lung
accessori
lobe
anim
collect
total
averag
weight
g
per
anim
pool
homogen
fastprep
homogen
mp
biomed
ml
transport
medium
quadrupl
serial
dilut
sampl
cultur
madindarbi
canin
kidney
cell
sampl
obtain
lung
standard
way
guid
chang
seen
gross
patholog
statist
analysi
use
analysi
varianc
anova
tukey
multipl
comparison
mean
compar
bodi
temperatur
rel
lung
weight
lung
viru
titer
percentag
affect
lung
parenchyma
histolog
immunohistochem
score
differ
level
lower
respiratori
tract
compar
score
pulmonari
lesion
viral
antigen
express
differ
consid
signific
p
cumul
mortal
rate
ferret
inocul
new
viru
increas
progress
dose
tcid
dose
tcid
intermedi
cumul
mortal
rate
infect
season
viru
infect
hpai
viru
figur
basi
data
estim
median
lethal
dose
tcid
hpai
viru
tcid
new
viru
tcid
season
viru
inocul
dose
tcid
allow
best
discrimin
cumul
mortal
rate
virus
perform
addit
compar
clinic
patholog
virolog
studi
ferret
inocul
dose
clinic
sign
observ
ferret
inocul
tcid
new
viru
day
inocul
onward
sign
includ
lethargi
loss
appetit
dyspnea
rais
bodi
temperatur
figur
contrast
season
viru
group
show
obviou
clinic
sign
time
point
inocul
bodi
temperatur
new
viru
group
significantli
higher
season
viru
group
day
day
p
p
inocul
tukey
test
hpai
viru
p
p
group
show
sever
clinic
sign
new
viru
group
ferret
die
euthan
moribund
state
day
inocul
increas
bodi
temperatur
hpai
viru
group
compar
new
viru
group
day
inocul
later
time
point
decreas
due
progress
moribund
state
ferret
mean
loss
bodi
weight
standard
deviat
new
viru
group
season
viru
group
day
inocul
sneez
observ
ferret
necropsi
day
inocul
rel
lung
weight
figur
lung
viru
titer
figur
ferret
inocul
new
viru
multifoc
coalesc
pulmonari
lesion
dark
red
rais
firmer
normal
figur
percentag
lung
parenchyma
affect
consolid
among
viru
group
significantli
differ
anova
p
p
percentag
affect
lung
parenchyma
f
p
new
viru
group
rang
intermedi
season
viru
group
rang
tukey
test
hpai
viru
p
p
group
tukey
test
p
p
histopatholog
examin
alveoli
new
viru
group
hpai
viru
group
show
diffus
alveolar
damag
figur
wherea
alveoli
season
viru
group
lesion
character
flood
alveolar
lumina
alveolar
macrophag
neutrophil
erythrocyt
mix
fibrin
edema
fluid
cellular
debri
alveolar
wall
thicken
necrosi
line
epithelium
multifoc
type
pneumocyt
hyperplasia
qualit
alveolar
parenchyma
new
viru
group
infiltr
inflammatori
cell
wherea
hpai
viru
group
necrosi
edema
bronchiolar
epithelium
new
viru
group
multifoc
necrosi
moder
infiltr
neutrophil
multifoc
peribronchiolar
infiltr
moder
number
macrophag
lymphocyt
neutrophil
plasma
cell
bronchiolar
lumen
moder
number
macrophag
neutrophil
erythrocyt
mix
fibrin
edema
fluid
cellular
debri
bronchi
peribronchi
infiltr
moder
number
lymphocyt
macrophag
plasma
cell
macrophag
bronchial
lumina
moder
amount
cellular
debri
fibrin
edema
neutrophil
hpai
season
viru
group
bronchiolar
bronchial
lesion
less
sever
overal
new
viru
group
quantit
histolog
score
show
alveolar
lesion
new
viru
group
intermedi
sever
season
viru
group
hpai
viru
group
bronchiolar
lesion
new
viru
group
sever
group
figur
immunohistochem
analysi
influenza
viru
antigen
express
visibl
diffusetogranular
red
stain
usual
stronger
nucleu
cytoplasm
figur
influenza
viru
antigen
express
close
associ
presenc
histolog
lesion
differ
level
lower
respiratori
tract
new
viru
hpai
viru
group
influenza
viru
antigen
express
seen
predominantli
type
pneumocyt
figur
alveolar
macrophag
bronchiolar
epitheli
cell
bronchial
epitheli
cell
season
viru
group
influenza
viru
antigen
express
seen
cell
type
rare
level
lower
respiratori
tract
quantit
score
show
influenza
viru
antigen
express
new
viru
group
high
level
lower
respiratori
tract
alveoli
bronchiol
bronchi
figur
contrast
influenza
viru
antigen
express
hpai
viru
group
highest
alveoli
lower
bronchiol
bronchi
season
viru
group
promin
bronchi
low
level
immunohistochem
score
among
viru
group
differ
significantli
alveoli
anova
bronchi
new
viru
group
significantli
f
p
higher
immunohistochem
score
season
viru
group
alveoli
tukey
test
bronchi
p
tukey
test
significantli
higher
immunohistop
p
chemic
bronchial
score
hpai
viru
group
tukey
test
hpai
group
significantli
p
p
higher
immunohistochem
alveolar
score
season
group
tukey
test
none
ferret
p
season
viru
new
viru
group
signific
lesion
influenza
viru
antigen
express
extrarespiratori
tissu
hallmark
infect
ferret
hpai
viru
caus
major
pandem
newli
emerg
influenza
viru
need
effici
transmiss
among
human
also
must
abl
caus
sever
pneumonia
former
demonstr
epidemiolog
analysi
spread
human
popul
provid
estim
r
rang
compar
lower
estim
obtain
r
previou
pandem
corrobor
previou
studi
show
ferrettoferret
transmiss
new
viru
equal
effici
season
viru
intranas
inocul
show
new
viru
effici
transmiss
also
abl
caus
sever
pneumonia
ferret
factor
held
constant
new
viru
caus
pneumonia
intermedi
sever
caus
season
viru
caus
hpai
viru
new
viru
share
hpai
viru
abil
replic
well
epitheli
cell
lower
respiratori
tract
caus
diffus
alveolar
damag
result
correspond
itoh
et
al
found
ferret
inocul
intranas
new
influenza
viru
show
sever
bronchopneumonia
inocul
recent
season
viru
pattern
influenza
viru
attach
lower
respiratori
tract
similar
ferret
human
influenzaassoci
diseas
ferret
resembl
human
similar
pattern
infect
associ
diseas
new
viru
may
also
expect
occur
human
corrobor
clinic
character
patient
confirm
fatal
infect
new
viru
acut
respiratori
distress
syndrom
frequent
diagnosi
warn
studywith
caveat
anim
model
abl
captur
aspect
human
diseasei
intrins
abil
new
viru
caus
sever
pneumonia
season
viru
fact
need
taken
account
ongo
pandem
prepared
plan
furthermor
regular
evalu
sever
pneumonia
caus
new
viru
ferret
model
provid
valuabl
inform
possibl
chang
virul
newli
emerg
viru
adapt
human
host
